Trial and new drug for Tourette Syndrome after $250M after funding round completed

Five latest advancements in Tourette’s syndrome research

Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures

Noema Pharma raises $112 million in Series B financing 

ADVERTISEMENT
In Depth 5 Dec 2022

The biggest private biotech investments in November 2022

Health Awareness Days